France to have second notified body from January: d
This article was originally published in Clinica
Executive Summary
France is to have a second notified body (NB) for medical devices diagnostics. The health ministry has accredited the National Testing Laboratory, the Laboratoire Nationale d'Essais, to begin work as from January 1 2005, according to a Decision that appeared in the Journal officiel of November 14. The LNE has been accredited to test: active implantables against annexes II to V of the Active Implantable Medical Device Directive; all medical devices, including class I sterile and with a measuring function, against annexes II to VI of the Medical Devices Directive; and self-testing and Annex II diagnostic products (lists A and B) against annexes III to VII of the IVD Directive. G-Med is the other French NB.
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.